Novartis Ophthalmics
  Novartis Pharma US

 
CHANGE TEXT SIZE  Decrease Font Size Increase Font Size
Helpful Hints
Help your patients understand how their eyes work, how to care for their eyes, their children's eyes, and what tests they may receive during an eye exam.
Find Out How >

Advancing Excellence in Ophthalmology

Miochol®–E (acetylcholine chloride intraocular solution) 1:100 with electrolyte diluent



Miochol®-E

Miochol-E is indicated to obtain complete miosis of the iris in seconds after delivery of the lens in cataract surgery in penetrating keratoplasty, iridectomy, and other anterior segment surgery in which rapid miosis may be required. Miochol-E is classified as a parasympathomimetic and available only by prescription.

Preparation and Usage

Miochol-E Injection Guide

For further instructions, please see the full Prescribing Information.

Important Safety Information

Infrequent cases of corneal edema, corneal clouding, and corneal decompensation have been reported with use of intraocular acetylcholine. Adverse reactions have been reported rarely which are indicative of systemic absorption. These include bradycardia, hypotension, flushing, breathing difficulties, and sweating.

Contraindications

Miochol-E should not be used by anyone with a known hypersensitivity to any of its active or inactive ingredients.

Active ingredient: Acetylcholine chloride.

Inactive ingredients: Mannitol, water (for injection), sodium acetate trihydrate, magnesium chloride hexahydrate, potassium chloride, calcium chloride dihydrate.

Full Prescribing Information

Back to Top


EYE DISEASES & DISORDERS
Facts on specific eye diseases
Read More >



Home  |  Professional Main Page  |  About Ophthalmics  |  Products
Eye Diseases & Disorders  |  Patient Education Library
Patient Assistance Program  |  Press Releases

Contact Us  |  Site Guide  |  Site Map

Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2007
Novartis Pharmaceuticals Corporation. All rights reserved.